Loading…

Antiphospholipid Antibodies as Key Players in Systemic Lupus Erythematosus: The Relationship with Cytokines and Immune Dysregulation

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by an overproduction of cytokines, such as interleukins and interferons, contributing to systemic inflammation and tissue damage. Antiphospholipid syndrome is a thrombo-inflammatory autoimmune disease affecting a third...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2024-10, Vol.25 (20), p.11281
Main Authors: Richter, Patricia, Badescu, Minerva Codruta, Rezus, Ciprian, Ouatu, Anca, Dima, Nicoleta, Popescu, Diana, Burlui, Alexandra Maria, Bratoiu, Ioana, Mihai, Ioana Ruxandra, Rezus, Elena
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by an overproduction of cytokines, such as interleukins and interferons, contributing to systemic inflammation and tissue damage. Antiphospholipid syndrome is a thrombo-inflammatory autoimmune disease affecting a third of SLE patients. We performed an in-depth analysis of the available literature, and we highlighted the complex interplay between immunity, inflammation, and thrombosis, the three major pathogenic pathways that are trapped in a mutually reinforcing destructive loop.
ISSN:1422-0067
1661-6596
1422-0067
DOI:10.3390/ijms252011281